Lockdowns are lifting, but many workers are not returning to their offices, and when they do come in, their needs are changing. So what does this mean for office design? Alex Love asks office design specialists how they expect designs to change and what challenges it will present.

Wellbeing has been an increasing focus for architects for some time, and with the outbreak of the coronavirus, this has been drawn into a renewed interest in public space design. Design & Build Review looks at some of the recently proposed projects that draw both together.

From drones to air taxis, the future of aviation is efficient, green and – above all – exciting. Lucy Ingham speaks to David Tait, head of innovation at the UK’s Civil Aviation Authority, to find out what lies ahead and how the organisation is helping to make the future a reality.

The coronavirus pandemic has driven a global shift in the way public spaces are perceived, and airports are no exception. Airport Industry Review hears from design agency Corgan’s aviation studio about how airport developers may approach design strategies differently in years to come.

The British government has given £37m of funding to electrify the nation's transport network as part of its ambition to achieve net zero emissions by 2050. But is the distribution and supply side also preparing for the increase in demand? Future Power Technology finds out. 

Oren, a global B2B digital mining services marketplace created in partnership between IBM and Royal Dutch Shell, aims to accelerate the digitisation of the mining industry by hosting new technologies and digital systems on one platform. 

As the popularity of electric vehicles continues to surge, Future Power Technology looks at the possibility of an accelerated EV rollout, and profiles five of the infrastructure companies poised to make the best out of this opportunity.

AI has revolutionised healthcare by dramatically speeding up drug discovery and development. Despite this, patent offices have made it clear that because AI is it not human, it cannot be classed as an inventor in its own right. Pharma Technology Focus asks how patent law needs brought up to date to reflect the important contribution AI makes to inventions in pharma.

Racism in medicine has consistently led to negative healthcare outcomes for people of colour, and racial bias is now littered through the healthcare decision-making algorithms clinicians use to support individual patient care. But what if artificial intelligence could be the key to fixing racial bias in medicine, instead of encoding it?